This article thematizes treatments in children affected by Acute Lymphocytic Leukemia. For this, treatment in patients from low-risk and high-risk groups will be addressed to the importance of diagnosis, bringing the expected results. Aiming at the process that the child patient receives, from the diagnostic to the treatments developed to reach the cure. This study was conducted from a literature review perspective, which consists of developing a theoretical basis, in the treatment of a research problem that can be answered in the analysis of a published literature. Therefore, this article is based on obtaining the study about articles that described several cases of acute lymphocytic leukemia. During this study it was possible to understand the results through treatment of patients with different degrees of the disease, each with its peculiarities, symptoms and treatment 2

This paper aims to discuss what has been written about the treatment of patients with CKD in recent years. For this, it is intended: to make a simple bibliographic survey of articles published in the years 2018-2021, to perform a brief analysis about the results and to comment on the most used treatments. After the research, it was possible to find a total of 691 articles produced in Brazil. However, some of the findings corroborated the understanding that CKD treatment occurs from two main intervention models: dialysis and kidney transplantation. It was observed with the study that the treatment modalities (RRT and TR) can cause profound impacts on the quality of life of the subject, which makes attention and attention necessary and sensitivity of health teams to better align their practices and approximate patient demands.

It is known that advanced chronic kidney disease in the patient leads to the need for transplantation, and, consequently, to the use of immunosuppressants, which are drugs that prevent rejection of the transplanted organ. The present work is a literature review and aims to analyze the side effects of immunosuppressants in renal transplant patients. From studies 2

Covid-19 is a highly infectious disease caused by the new Coronavirus, which was identified in Wuhan in China and caused covid-19, 11,821 cases and 259 deaths were recorded in the first 30 days of infection, it is known that the disease causes clinical changes, so hematology is a type of test that analyzes information about the types and amounts of components in the blood as: Red blood cells; White blood cells; Platelets. The present study aimed to present the main hematological alterations found in patients hospitalized by Covid-19. The most prevalent mild symptoms include fever and cough, while in severe patient's respiratory failure occurs, so it is possible to observe in the blood test a significant decrease (10% -20%) of oxygen saturation. However, it was observed that there was a prevalence of changes related to leukocytes and platelets, however, lymphopenia was also present in reports made by authors.